Andere Sprachen BetterLife Pharma Inc. Canadian Securities Exchange

Aktien

A2P7XN

CA08772P2026

BETR

Markt geschlossen - Canadian Securities Exchange Andere Börsenplätze 16:50:44 15.05.2024			% 5 Tage	% 1. Jan.
0.125 ^CAD	0.00%		-3.85%	+108.33%

14.05.	BetterLife erhält hervorragende kardiopulmonale Sicherheitsdaten für oral verabreichtes BETR-001	CI
01.05.	BetterLife Pharma treibt die IND-zulassenden Studien für BETR-001 voran	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

BetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001	14.05.
BetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001	14.05.
BetterLife Announces Intent to Complete Private Placement of Units	04.05.
BetterLife Announces Intent to Complete Private Placement of Units	04.05.
BetterLife Pharma Inc. announced that it expects to receive CAD 0.5 million in funding	03.05.
BetterLife Pharma Advances IND-enabling Studies For BETR-001	01.05.
BetterLife Advances BETR-001 IND-enabling Studies	01.05.
BetterLife Advances BETR-001 IND-enabling Studies	01.05.
BetterLife Pharma Inc. Advances BETR-001 IND-Enabling Studies	01.05.
BetterLife Pharma Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	15.04.
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	11.04.
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	11.04.
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001	03.04.
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001	03.04.
BetterLife Pharma Inc. announced that it has received CAD 1.168 million in funding	03.04.
BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University	04.03.
BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University	04.03.
BetterLife Pharma Inc. announced that it expects to receive CAD 0.1 million in funding	04.03.
BetterLife Pharma Inc. announced that it has received CAD 0.065 million in funding	04.03.
BetterLife Closes Convertible Debentures For Further Development of BETR-001	02.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen BetterLife Pharma Inc. Canadian Securities Exchange

Aktien

A2P7XN

CA08772P2026

BETR

Andere Sprachen

Filter